|
Pharmacotherapy: A Pathophysiologic Approach, 7e
5/29/2009: KRAS Mutations Predict Response to Anti-Epidermal Growth Factor Receptor Antibodies in Advanced Colorectal Cancer
Jennifer Ludwig
The Nebraska Medical Center and the University of Nebraska Medical Center, Omaha
Gary C. Yee
The Nebraska Medical Center and the University of Nebraska Medical Center, Omaha
Topics Discussed: cetuximab; colorectal cancer; colorectal cancer metastatic; genetic basis for disease and drug action; genomic medicine; molecular genetics, recombinant dna, and genomic technology; monoclonal antibodies; mutation; mutation and inherited disease; pharmacogenomics; pharmacogenomics and drug development; receptor, epidermal growth factor; the genetics of cancer.
Related to Chapter 133. Colorectal Cancer; View in chapter;
Excerpt:
"View in chapter..."
|
|
|
|
|